Status:

UNKNOWN

Acupuncture for Prevention of Postoperative Nausea and Vomiting

Lead Sponsor:

Nigde Omer Halisdemir University

Conditions:

PONV

Eligibility:

FEMALE

18-65 years

Phase:

NA

Brief Summary

The aim of this study is to compare the single point stimulation (P6) and double point stimulation (P6+ST36) performed before anesthesia induction with standard treatment in terms of PONV development ...

Detailed Description

Postoperative nausea and vomiting (PONV) is encountered in 20-30% of patients undergoing surgery. PONV is a costly medical condition in financial and emotional aspects by causing serious complications...

Eligibility Criteria

Inclusion

  • Women between 18-65 years old, who have ASA scores of I-II-III and who are planned to undergo elective laparoscopic cholecystectomy.

Exclusion

  • Pregnant women
  • Lactating women
  • Women with steel hypersensitivity
  • Mental retarded patients
  • Patients with psychological disorders and neurologic sequel
  • Additionally, patients who;
  • have nausea/vomiting, consume anti-emetic or emetogenic drugs, alcohol, opioid drugs, glucocorticoid drug and have acupuncture treatment for any reason 72 hours prior to surgery
  • have skin reactions at the site of acupuncture application
  • had intraoperative gangrenous cholecystitis, gall bladder perforation, malignant pathological outcome
  • were admitted to intensive care unite
  • had to convert to open surgery will be excluded.

Key Trial Info

Start Date :

May 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2022

Estimated Enrollment :

105 Patients enrolled

Trial Details

Trial ID

NCT04866121

Start Date

May 1 2021

End Date

May 1 2022

Last Update

May 3 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Niğde Ömer Halisdemir University Training and Research Hospital

Niğde, Turkey (Türkiye)

Acupuncture for Prevention of Postoperative Nausea and Vomiting | DecenTrialz